11:53 AM EST - Cardiome Pharma Corp. : reported financial results for the second quarter ended June 30, 2013. Amounts, unless specified otherwise, are expressed in U.S. dollars. Cardiome reported a net loss of $2.8 million ($0.22 per common share) for the three months ended June 30, 2013 (Q2-2013), compared to a net loss of $5.7 million ($0.46 per common share) for the three months ended June 30, 2012. Cardiome Pharma Corp.
shares T.COM are trading up $0.12 at $2.27.
